Re: Xu N, Zhou W, Shuy L, Zhou G, Zhang N. Clinical and MRI characteristics of Levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging 2009;13:326-331.
John W
JW
Gilbert
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000969:Antinematodal Agents / Q000009:adverse effects*; D001196:Ascariasis / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D002681:China; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000473:pathology; D038524:Diffusion Magnetic Resonance Imaging; D006801:Humans; D056784:Leukoencephalopathies / Q000139:chemically induced* / Q000473:pathology*; D007978:Levamisole / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D013281:Stomatitis, Aphthous / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000969:Antinematodal Agents; D007978:Levamisole